Hematologic safety of Ra-223 dichloride (Ra-223) in castration-resistant prostate cancer (CRPC) patients with bone metastases from the phase III ALSYMPCA trial.
Chris Parker
Consultant or Advisory Role - Algeta; Bayer; BN ImmunoTherapeutics
Honoraria - Amgen; Astellas Pharma; Bayer; Janssen; Sanofi ; Takeda
Jose E. Garcia-Vargas
Employment or Leadership Position - Bayer
Stock Ownership - Bayer
C. Gillies O'Bryan-Tear
Employment or Leadership Position - Algeta
Stock Ownership - Algeta
Fang Fang
Employment or Leadership Position - Bayer
Stock Ownership - Bayer
Nicholas J. Vogelzang
Employment or Leadership Position - US Oncology
Consultant or Advisory Role - Algeta/Bayer